BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nicergoline

An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS.

300+ PubMed studies analyzed · 32 RCTs · Evidence Score: 47.7

Research Domains

Nicergoline has been studied across 20 research domains including 🧠 Neuroprotection, ❤️ Cardiovascular, 🧠 Cognitive, 🧠 Focus & Attention, ⏳ Longevity & Aging. The primary research focus is 🧠 Neuroprotection with 17% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nicergoline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Thiethylperazine
10 shared targets
ethopropazine
9 shared targets
Piribedil
10 shared targets
Lysergic
15 shared targets
Loxapine
11 shared targets
Nylidrin
10 shared targets
Cabergoline
11 shared targets
pirenperone
10 shared targets
Riboflavin
10 shared targets
Promazine
11 shared targets
Loading evidence profile...

This evidence profile for Nicergoline is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.